Maspin expression and melanoma progression: A matter of sub-cellular localization

Modern Pathology

Volumn 27, Issue 3, 2014, Pages 412-419

  Martinoli, Chiara ^a   Gandini, Sara ^a   Luise, Chiara ^a   Mazzarol, Giovanni ^a   Confalonieri, Stefano ^a   Giuseppe Pelicci, Pier ^a   Testori, Alessandro ^a   Ferrucci, Pier Francesco ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Biomarker; Maspin; Melanoma; Tissue microarrays

Indexed keywords

MASPIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CYTOPLASM; DISEASE FREE SURVIVAL; DYSPLASTIC NEVUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG METASTASIS; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; METASTASIS; MITOSIS RATE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; ULCER;

CELL NUCLEUS; CYTOPLASM; DISEASE PROGRESSION; HUMANS; KAPLAN-MEIER ESTIMATE; MELANOMA; NEOPLASM METASTASIS; PROPORTIONAL HAZARDS MODELS; SERPINS; SKIN NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84896729888     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.157     Document Type: Article

References (32)

1. Mouawad R, Sebert M, Michels J, et al. Treatment for metastatic malignant melanoma: old drugs and new strategies. Crit Rev Oncol Hematol 2010;74: 27-39.
2. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27: 6199-6206.
3. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263: 526-529.
4. Maass N, Hojo T, Rosel F, et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 2001;34: 303-307.
5. Umekita Y, Ohi Y, Sagara Y, et al. Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 2002;100: 452-455.
6. Machtens S, Serth J, Bokemeyer C, et al. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 2001;95: 337-342.
7. Beecken WD, Engl T, Engels K, et al. Clinical relevance of maspin expression in bladder cancer. World J Urol 2006;24: 338-344.
8. Yasumatsu R, Nakashima T, Hirakawa N, et al. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 2001;23: 962-966.
9. Takanami I, Abiko T, Koizumi S. Expression of maspin in non-small-cell lung cancer: correlation with clinical features. Clin Lung Cancer 2008;9: 361-366.
10. Sheng S, Carey J, Seftor EA, et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 1996;93: 11669-11674.
11. Seftor RE, Seftor EA, Sheng S, et al. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 1998;58: 5681-5685.
12. Shi HY, Zhang W, Liang R, et al. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 2001;61: 6945-6951.
13. Odero-Marah VA, Khalkhali-Ellis Z, Chunthapong J, et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol Ther 2003;2: 398-403.
14. Zhang M, Volpert O, Shi YH, et al. Maspin is an angiogenesis inhibitor. Nat Med 2000;6: 196-199.
15. Jiang N, Meng Y, Zhang S, et al. Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 2002;21: 4089-4098.
16. Liu J, Yin S, Reddy N, et al. Bax mediates the apoptosis-sensitizing effect of maspin. Cancer Res 2004;64: 1703-1711.
17. Zhang W, Shi HY, Zhang M. Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins. BMC Cancer 2005;5:50.
18. Tahmatzopoulos A, Sheng S, Kyprianou N. Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene 2005;24: 5375-5383.
19. Li Z, Shi HY, Zhang M. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 2005;24: 2008-2019.
20. Bettstetter M, Woenckhaus M, Wild PJ, et al. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 2005;205: 606-614.
21. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 2001;7: 812-817.
22. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002;8: 2924-2932.
23. Mohsin SK, Zhang M. Clark GM et al. Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 2003;199: 432-435.
24. Pemberton PA, Tipton AR, Pavloff N, et al. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J Histochem Cytochem 1997;45: 1697-1706.
25. Khalkhali-Ellis Z, Hendrix MJ. Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation. Cancer Res 2007;67: 3535-3539.
26. Markl B, Arnholdt HM, Jahnig H, et al. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. Hum Pathol 2010;41: 1024-1033.
27. Denk AE, Bettstetter M, Wild PJ, et al. Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res 2007;20: 112-119.
28. Villares GJ, Zigler M, Dobroff AS, et al. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proc Natl Acad Sci USA 2011;108: 626-631.
29. Wada K, Maesawa C, Akasaka T, et al. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells. J Invest Dermatol 2004;122: 805-811.
30. Vereecken P, Reynaert S, Lalmand MC, et al. Decreased immunoreactive maspin expression in intermediate thickness and thick primary melanoma lesions. J Int Med Res 2006;34: 52-57.
31. Chua R, Setzer S, Govindarajan B, et al. Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. J Am Acad Dermatol 2009;60: 758-766.
32. Goulet B, Chan G, Chambers AF, et al. An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis. Biochem Cell Biol 2012;90: 22-38.